Dorsey Wright & Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Dorsey Wright & Associates's LLY Position: Q1 2026 in Review
Dorsey Wright & Associates opened a new position in Eli Lilly (LLY) in Q1 2026: 508 shares worth $468K. The stake represents 0.06% of the portfolio and ranks #142 among its holdings. This is a return to the name: Dorsey Wright & Associates previously reported a position in LLY as recently as Q3 2025.
Dorsey Wright & Associates first reported a position in LLY in Q3 2015 and has held it in 21 quarters since. The position peaked at $16.7M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Dorsey Wright & Associates held 508 shares of Eli Lilly worth $468K as of Q1 2026.
- Eli Lilly was a new Dorsey Wright & Associates position in Q1 2026.
- Eli Lilly made up 0.06% of Dorsey Wright & Associates's portfolio in Q1 2026, its #142 holding.
- Dorsey Wright & Associates first reported a position in Eli Lilly in Q3 2015 and has held it in 21 quarters since.
- Dorsey Wright & Associates's Eli Lilly position peaked at $16.7M in Q2 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Dorsey Wright & Associates's 13F filing for Q1 2026, filed 6 May 2026.